Literature DB >> 23060403

Liver transplantation in Crigler-Najjar syndrome type I disease.

Zhen-Hua Tu1, De-Sheng Shang, Jin-Cai Jiang, Wu Zhang, Min Zhang, Wei-Lin Wang, Hai-Yan Lou, Shu-Sen Zheng.   

Abstract

BACKGROUND: Crigler-Najjar syndrome type I (CNS I) is a very rare autosomal recessive inherited disease that liver transplantation can properly deal with.
METHODS: We present one case of an 18-month-old child with CNS I diagnosed by clinical findings and genetic detecting. LTx was performed 5 days after kernicterus broke out and neurological symptoms were successfully reversed. RESULT: Magnetic resonance imaging and magnetic resonance spectroscopy showed encouraging results that brain pathology had a trend to return to normal in 1-year follow-up, combined with electroencephalogram and motor development estimate studies.
CONCLUSIONS: Liver transplantation can cure CNS I with reversible neurological symptoms to some extent in time. Magnetic resonance spectroscopy may be a future option of predicting brain conditions and selecting suitable patients with CNS I for transplantation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23060403     DOI: 10.1016/s1499-3872(12)60222-7

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  4 in total

1.  PNPO Deficiency and Cirrhosis: Expanding the Clinical Phenotype?

Authors:  D Coman; P Lewindon; P Clayton; K Riney
Journal:  JIMD Rep       Date:  2015-06-25

Review 2.  Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases.

Authors:  Zeljka Trepotec; Eva Lichtenegger; Christian Plank; Manish K Aneja; Carsten Rudolph
Journal:  Mol Ther       Date:  2018-12-22       Impact factor: 11.454

3.  Efficacy of AAV8-hUGT1A1 with Rapamycin in neonatal, suckling, and juvenile rats to model treatment in pediatric CNs patients.

Authors:  Xiaoxia Shi; Sem J Aronson; Lysbeth Ten Bloemendaal; Suzanne Duijst; Robert S Bakker; Dirk R de Waart; Giulia Bortolussi; Fanny Collaud; Ronald P Oude Elferink; Andrés F Muro; Federico Mingozzi; Giuseppe Ronzitti; Piter J Bosma
Journal:  Mol Ther Methods Clin Dev       Date:  2020-12-03       Impact factor: 6.698

4.  Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome.

Authors:  Fanny Collaud; Giulia Bortolussi; Laurence Guianvarc'h; Sem J Aronson; Thierry Bordet; Philippe Veron; Severine Charles; Patrice Vidal; Marcelo Simon Sola; Stephanie Rundwasser; Delphine G Dufour; Florence Lacoste; Cyril Luc; Laetitia V Wittenberghe; Samia Martin; Christine Le Bec; Piter J Bosma; Andres F Muro; Giuseppe Ronzitti; Matthias Hebben; Federico Mingozzi
Journal:  Mol Ther Methods Clin Dev       Date:  2018-12-31       Impact factor: 6.698

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.